Compass Therapeutics (CMPX) Debt Ratio (2018 - 2021)

Compass Therapeutics has reported Debt Ratio for 3 years, with the latest figure at 0.11 in Q3 2021.

• Quarterly Debt Ratio fell 41.82% year-over-year to 0.11 in Q3 2021, while the trailing twelve-month figure through Sep 2021 was 0.11 (down 41.82% YoY) and the FY2020 annual result came in at 0.18, down 63.26% from the prior year.
• Debt Ratio eased to 0.11 in Q3 2021 per CMPX's latest filing, from 0.16 in the prior quarter.
• Over five years, Debt Ratio peaked at 0.49 in Q4 2019 and troughed at 0.11 in Q3 2021.
• A 3-year average of 0.22 and a median of 0.18 in 2020 frame the typical range for Debt Ratio.
• The sharpest annual moves came in 2020 and 2021: Debt Ratio slumped 63.26% in 2020, then sank 41.82% in 2021.
• Over 3 years, Debt Ratio stood at 0.49 in 2019, then tumbled by 63.26% to 0.18 in 2020, then sank by 40.34% to 0.11 in 2021.
• According to Business Quant data, Debt Ratio over the past three periods registered 0.11, 0.16, and 0.18 for Q3 2021, Q1 2021, and Q4 2020 respectively.